αIIb TMD-tail binds to the β3 subunit of native integrin αIIbβ3. (A) αIIbTM-TAP, αIIbTMΔGFFKR-TAP, or empty vector was transfected into A5 cells, and after 24 hours, cells were lysed and incubated with calmodulin beads to capture TAP constructs. β3 was detected by Western blot using anti-β3 antibody as representative of the bound αIIbβ3 (top). Expression level of β3 in lysates (middle) and captured TAP constructs (bottom) was assessed by Western blot. (B) A5 cells transfected with Tac-αIIbTM or Tac-αIIb were detached and stained with anti-Tac antibody and PAC1. In the merged image, green and red represent Tac and active integrin, respectively. The 2.7-fold digital enlargement of areas in small rectangles is shown in insets. Bar = 5 μm. (C) A5 cells were incubated for 30 minutes at 37°C with TBS (20 mM Tris, pH 8.4, 150 mM NaCl) containing either 1 mM Ca/Mg or 5 mM EDTA, and stained with αIIbβ3 complex-specific antibody (D57). D57 binding was measured by flow cytometry and plotted as histogram. (D) A5 cells transfected with TAP constructs were detached, and surface proteins were biotinylated and treated with EDTA to dissociate αIIbβ3 complex before the cells were lysed. Five percent of the lysates were incubated with neutravidin beads to determine the input of biotinylated proteins in the lysates (lanes 5-8). The remaining lysates were first incubated with calmodulin beads to capture TAP tag, and the bound proteins were eluted with 10 mM EDTA. The eluates were further incubated with NeutrAvidin beads to capture the biotinylated protein (lanes 1-4). Anti-αIIb antibody (PMI-1), anti-β3 antibody (Rb8053), and anti-FLAG antibody (M2) were used for the Western blot, as indicated. Schematic procedure for this experiment is shown in Figure S4. (E) Model of how the αIIb TMD-tail induced αIIbβ3 activation. αIIb TMD-tail interacts with TMD-tail region of β3 in the native integrin and competes for the heterodimeric interaction between αIIb and β3, resulting in rearrangement of the TMD and activation.